INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Walleye Capital LLC's Holding History (CIK: 0001758720)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 383,591 Value ($000) $32,038 Avg Close — Range —
Q3 2024
Shares 249,388 Value ($000) $18,248 Avg Close — Range —
Q2 2024
Shares 235,787 Value ($000) $16,149 Avg Close — Range —
Q1 2024
Shares 155,138 Value ($000) $10,736 Avg Close — Range —
Q3 2023
Shares 134,655 Value ($000) $7,014 Avg Close — Range —
Q1 2023
Shares 226,402 Value ($000) $12,260 Avg Close — Range —
Q4 2022
Shares 209,712 Value ($000) $11,098 Avg Close — Range —
Q3 2022
Shares 205,563 Value ($000) $9,565 Avg Close — Range —
Q2 2022
Shares 97,410 Value ($000) $5,560 Avg Close — Range —
Q1 2022
Shares 69,719 Value ($000) $4,266 Avg Close — Range —
Q4 2021
Shares 17,878 Value ($000) $936 Avg Close — Range —
Q3 2021
Shares 104,425 Value ($000) $3,893 Avg Close — Range —
Q2 2021
Shares 87,653 Value ($000) $3,578 Avg Close — Range —
Q1 2021
Shares 64,054 Value ($000) $2,173 Avg Close — Range —
Q4 2020
Shares 65,400 Value ($000) $2,080 Avg Close — Range —
Q4 2019
Shares 41,068 Value ($000) $1,409 Avg Close — Range —
Q3 2019
Shares 18,300 Value ($000) $137 Avg Close — Range —
Q1 2019
Shares 7,605 Value ($000) $92 Avg Close — Range —